tradingkey.logo
tradingkey.logo
Search

Fennec Pharmaceuticals Inc

FENC
Add to Watchlist
9.570USD
-0.340-3.43%
Close 07-31 16:00ETQuotes delayed by 15 min
332.43MMarket Cap
LossP/E TTM

FENC Financials

See Fennec Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Fennec Pharmaceuticals Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
0.01/-0.01
Revenue / Forecast
15.11M/13.95M
Period
FY2025 Earnings
Revenue(YoY)
44.64M
-6.09%
EPS(YoY)
-0.34
-2034.44%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
113.85%0.01
-109.34%-0.15
89.08%-0.02
43.99%-0.11
-108.90%-0.04
26.91%-0.07
-198.48%-0.21
1.13%-0.20
308.30%0.47
60.80%-0.10
---0.07
---0.21
---0.23
---0.26
---0.65
----
----
----
----
----
Revenue
72.64%15.11M
73.84%13.78M
78.69%12.46M
32.91%9.65M
-65.52%8.75M
-18.59%7.92M
7.05%6.97M
118.41%7.26M
1413.24%25.38M
534.20%9.73M
--6.51M
--3.33M
--1.68M
--1.54M
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
Net Profit
117.25%201.00K
-141.16%-4.79M
88.88%-638.00K
43.24%-3.15M
-109.08%-1.17M
25.99%-1.98M
-207.18%-5.74M
-2.00%-5.55M
312.11%12.84M
60.89%-2.68M
76.92%-1.87M
-7.33%-5.44M
-63.74%-6.05M
-54.89%-6.86M
-93.29%-8.09M
-26.77%-5.07M
21.91%-3.70M
-36.72%-4.43M
32.50%-4.18M
17.42%-4.00M
Net Margin
109.99%1.33%
-38.72%-34.75%
93.77%-5.12%
57.29%-32.66%
-126.32%-13.31%
9.08%-25.05%
-186.96%-82.23%
53.30%-76.47%
114.02%50.59%
93.83%-27.55%
---28.66%
---163.73%
---360.88%
---446.71%
----
----
----
----
----
----
Gross Margin
0.51%96.23%
-4.76%87.20%
17.58%94.70%
-1.80%89.98%
-2.14%95.74%
-1.51%91.56%
-15.15%80.54%
-4.10%91.63%
3.71%97.83%
-1.52%92.96%
--94.92%
--95.55%
--94.34%
--94.40%
----
----
----
----
----
----
Debt to assets ratio
----
-100.00%0.00%
-27.41%36.96%
-14.59%40.57%
-9.51%39.23%
-63.73%40.51%
-61.25%50.92%
-63.07%47.50%
-62.16%43.36%
20.34%111.67%
--131.39%
--128.62%
--114.57%
--92.80%
--82.19%
----
----
----
----
----
Revenue
72.64%15.11M
73.84%13.78M
78.69%12.46M
32.91%9.65M
-65.52%8.75M
-18.59%7.92M
7.05%6.97M
118.41%7.26M
1413.24%25.38M
534.20%9.73M
--6.51M
--3.33M
--1.68M
--1.54M
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
Operating profit
85.27%-119.00K
-173.45%-2.55M
96.37%-189.00K
45.78%-2.73M
-105.88%-808.00K
48.62%-934.00K
-411.50%-5.20M
-7.99%-5.04M
360.78%13.74M
70.37%-1.82M
87.12%-1.02M
6.85%-4.67M
-48.62%-5.27M
-45.83%-6.13M
-89.29%-7.90M
-27.78%-5.01M
27.97%-3.55M
-25.73%-4.21M
28.78%-4.17M
19.09%-3.92M
Net Profit
117.25%201.00K
-141.16%-4.79M
88.88%-638.00K
43.24%-3.15M
-109.08%-1.17M
25.99%-1.98M
-207.18%-5.74M
-2.00%-5.55M
312.11%12.84M
60.89%-2.68M
76.92%-1.87M
-7.33%-5.44M
-63.74%-6.05M
-54.89%-6.86M
-93.29%-8.09M
-26.77%-5.07M
21.91%-3.70M
-36.72%-4.43M
32.50%-4.18M
17.42%-4.00M
Current assets
55.63%66.88M
51.94%67.04M
-20.53%46.06M
-34.39%40.79M
-36.96%42.98M
64.29%44.12M
205.95%57.97M
221.62%62.17M
214.70%68.17M
0.49%26.86M
-37.17%18.95M
24.28%19.33M
13.25%21.66M
19.39%26.73M
16.07%30.15M
-44.60%15.55M
-31.26%19.13M
-28.74%22.39M
-23.75%25.98M
-27.83%28.07M
Total current liabilities
14.51%9.59M
52.02%10.52M
32.01%9.81M
8.58%8.41M
-14.89%8.37M
-8.39%6.92M
90.01%7.43M
105.11%7.75M
144.68%9.84M
63.88%7.55M
33.69%3.91M
24.40%3.78M
88.20%4.02M
178.66%4.61M
45.33%2.93M
258.14%3.04M
-26.14%2.14M
-29.53%1.65M
-30.19%2.01M
-73.42%848.00K
Total assets
54.78%71.82M
56.97%70.55M
-16.39%49.26M
-28.95%44.88M
-32.94%46.40M
67.31%44.95M
209.65%58.92M
224.95%63.16M
217.09%69.19M
-0.28%26.86M
-37.44%19.03M
24.85%19.44M
13.95%21.82M
20.19%26.94M
16.93%30.42M
-44.63%15.57M
-31.18%19.15M
-28.66%22.41M
-23.65%26.01M
-28.49%28.11M
Total liabilities
-34.69%34.15M
-30.97%35.08M
-16.13%53.75M
-18.88%52.34M
-21.00%52.28M
32.04%50.82M
116.83%64.09M
121.22%64.52M
126.95%66.18M
30.43%38.49M
7.04%29.56M
315.03%29.16M
340.15%29.16M
344.26%29.51M
294.44%27.61M
20.45%7.03M
129.08%6.63M
183.00%6.64M
142.67%7.00M
82.88%5.83M
Total equity
740.73%37.67M
704.09%35.47M
13.13%-4.49M
-449.96%-7.46M
-295.09%-5.88M
49.48%-5.87M
50.90%-5.17M
86.05%-1.36M
141.07%3.01M
-352.39%-11.62M
-475.84%-10.53M
-213.89%-9.73M
-158.60%-7.34M
-116.29%-2.57M
-85.26%2.80M
-61.67%8.54M
-49.77%12.52M
-45.74%15.77M
-39.03%19.01M
-38.32%22.28M
Net operating income
147.76%2.07M
-303.78%-5.99M
163.74%1.44M
55.35%-3.79M
-111.09%-4.33M
69.59%-1.48M
18.39%-2.26M
-113.37%-8.48M
797.30%39.03M
28.59%-4.88M
46.41%-2.77M
-17.20%-3.97M
-95.97%-5.60M
-110.48%-6.83M
-74.98%-5.18M
23.41%-3.39M
20.51%-2.86M
1.19%-3.25M
45.68%-2.96M
-42.04%-4.43M
Net financing
256.60%1.32M
270.69%20.83M
482.77%1.80M
-153.31%-185.00K
133.33%371.00K
-312.34%-12.20M
-318.60%-470.00K
-35.86%347.00K
-622.54%-1.11M
574.53%5.75M
-98.93%215.00K
1076.09%541.00K
1320.00%213.00K
8420.00%852.00K
--20.01M
-99.07%46.00K
--15.00K
-97.84%10.00K
100.00%0.00
-84.45%4.97M

FAQs

What is the total revenue of Fennec Pharmaceuticals Inc?

According to Fennec Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 44.64M, with a year-on-year change of 47.54M.

What are the current assets of Fennec Pharmaceuticals Inc?

According to Fennec Pharmaceuticals Inc's FY2025 earnings report, its current assets were 67.04M, with a year-on-year change of 51.94.

What are the total assets of Fennec Pharmaceuticals Inc?

According to Fennec Pharmaceuticals Inc's FY2025 earnings report, its total assets of Fennec Pharmaceuticals Inc were 70.55M, with a year-on-year change of 56.97.

What are the total liabilities of Fennec Pharmaceuticals Inc?

According to Fennec Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Fennec Pharmaceuticals Inc were 35.08M, with a year-on-year change of -30.97.

What is the total equity of Fennec Pharmaceuticals Inc?

According to Fennec Pharmaceuticals Inc's FY2025 earnings report, its total equity of Fennec Pharmaceuticals Inc was 35.47M, with a year-on-year change of 704.09.

What is the net operating income of Fennec Pharmaceuticals Inc?

According to Fennec Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Fennec Pharmaceuticals Inc was -6.28M, with a year-on-year change of -344.63.

What is the net financing of Fennec Pharmaceuticals Inc?

According to Fennec Pharmaceuticals Inc's FY2025 earnings report, its net financing of Fennec Pharmaceuticals Inc was 22.81M, with a year-on-year change of 269.76.

What is the Earnings Per Share (EPS) of Fennec Pharmaceuticals Inc?

According to Fennec Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.34, with a year-on-year change of -2034.44.

What is the net income of Fennec Pharmaceuticals Inc?

According to Fennec Pharmaceuticals Inc's FY2025 earnings report, its net income was -9.74M, with a year-on-year change of -2134.17.

What is the net margin of Fennec Pharmaceuticals Inc?

According to Fennec Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -21.82, with a year-on-year change of -2279.11.

What is the gross margin of Fennec Pharmaceuticals Inc?

According to Fennec Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 91.57, with a year-on-year change of -1.86.

What is the Return on Assets (ROA) of Fennec Pharmaceuticals Inc?

According to Fennec Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -16.87, with a year-on-year change of -1289.09.

What is the operating profit of Fennec Pharmaceuticals Inc?

According to Fennec Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -6.28M, with a year-on-year change of -344.63.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.